- Acquired by DePuy Synthes, Nov 2021
- Raised $5M funding round led by Johnson & Johnson Innovation, Mar 2020
- Raised $3M funding round, Jul 2018
About
OrthoSpin is developing a smart external fixation system designed to allow real-time physician follow-up and reduce dependence on patient compliance. The system is composed of a strut powered by a lightweight motor and a control box placed on top of a circular hexapod fixation frame. The system automatically and continuously adjusts and lengthens the struts according to the prescribed treatment regimen, without patient involvement.
With OrthoSpin's smart system, physicians can be assured that the prescribed course of treatment is being followed. The company's proprietary software program allows physicians to chart patient progress and change the treatment schedule if necessary.
In September 2019, the company received regulatory clearance from the FDA for its smart robotic external fixation system for orthopedic treatment. In January 2021, the company received regulatory clearance from the FDA for its second-generation robotic, digitally enabled external fixation system for orthopedic treatments. The OrthoSpin G2 system is approved in Israel, cleared for use in the United States, and can be used with the DePuy Synthes MAXFRAME Multi-Axial Correction System.
OrthoSpin is part of the Trendlines Group.
Funding history · 3 rounds · $8.0M total
Q&A
- What is OrthoSpin's primary business?
- OrthoSpin develops a smart external fixation system that uses robotics to automatically adjust and lengthen struts for orthopedic treatment, allowing real-time physician follow-up and reducing patient compliance dependence.
- When was OrthoSpin acquired and by whom?
- OrthoSpin was acquired by DePuy Synthes in November 2021.
- What was OrthoSpin's total funding raised before its acquisition?
- OrthoSpin raised a total of $8 million in funding.
- Which investors participated in OrthoSpin's March 2020 funding round?
- The March 2020 funding round included investment from Johnson & Johnson Innovation.
- When did OrthoSpin receive FDA clearance for its second-generation system?
- In January 2021, OrthoSpin received regulatory clearance from the FDA for its second-generation robotic, digitally enabled external fixation system for orthopedic treatments.
- What is the status of OrthoSpin's G2 system?
- The OrthoSpin G2 system is approved in Israel, cleared for use in the United States, and can be used with the DePuy Synthes MAXFRAME Multi-Axial Correction System.
- When was OrthoSpin founded?
- OrthoSpin was founded in December 2014.
Team · 1
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | orthospin.com |
|---|---|
| linkedin.com/company/29001774 |
Identifiers & details
| Founded | 2014-12 |
|---|---|
| Employees (exact) | 4 |
| Status reason | Acquired by DePuy Synthes on Nov, 2021 |
Acquisitions & public offerings
Acquired by DePuy Synthes 2021-11
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | orthospin.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|